ACE2 and COVID-19: However, pancreatic ACE2 expression is of particular interest due to a rising number of reports pointing out a surge in patients with new-onset hyperglycemia and ketoacidosis and giving rise to questions about whether COVID-19 actually induces diabetes via β-cell injury (27, 66–70).